Abstract:Background Ischemic stroke and thromboembolism are the major complications of atrial fibrillation (AF), however, its association with genetic background of AF remains unclear. To investigate the association between genetic predisposition of AF underlying common variants and the risk of ischemic stroke and thromboembolism. Methods We included unrelated individuals with non-valvular AF from UK biobank. The polygenic risk scores of AF (PRSAF) was calculated for each individual using the effect weight from a previous study which has been validated in both European and mixed-ancestry population[1, 2]. The SNPs from the original score were lifted over to GRCh38 and 6514708 of 6730541 were available in the UK biobank genotype data. The clinical data was defined by ICD-10 code. The primary endpoint is ischemic stroke or thromboembolism resulting in hospitalization after first AF diagnosis. Results A total of 28810 unrelated patients were included in the study. Among them, 4064 had PRSAF over 90th percentile of the general population, and were considered having high genetic risk. The rest 18746 with per SD increase in PRSAF lower than 90th percentile of the general population were considered having lower genetic risk. Generally, age and sex adjusted model demonstrated that per standard deviation change in PRSAF is associated with 9% increase in the risk of stroke or thromboembolism (HR=1.09, 95%CI: 1.03-1.14), and patients with high genetic risk was associated with 15% increase in the risk of stroke or thromboembolism (HR=1.15, 95%CI: 1.02-1.31).The result remained stable when further adjusted for clinical risk factors (1.09, 95%CI: 1.04-1.15 per SD increase in PRSAF) and competing risk of death (1.10, 95%CI: 1.05-1.16 per SD increase in PRSAF). There was no interaction between CHA2DS2-VASc score risk stratification and the per SD increase in PRSAF (P interaction = 0.751, Figure 1A). However, the association between per SD increase in PRSAF and the event tended to be affected by age at AF onset (HR = 1.02 95%CI: 0.94, 1.11 for early onset AF; HR = 1.12 95%CI: 1.05, 1.19 for non-early onset AF, P for interaction = 0.062, Figure 1B). Multi-variate COX regression including PRSAF, components of CHA2DS2-VASc score, and other AF risk factors revealed that history of stroke/thromboembolism, age over 65 years, hypertension, diabetes and high AF genetic risk were significantly associated with the outcome (Figure 1C). To evaluate the importance of these risk factors, average population attributable fraction for 10-year risk of stroke/thromboembolism in the study population was calculated, indicating that genetic risk of AF is responsible for 3.26% (0.89%-5.63%) of the events (Figure 1D). Conclusion Genetic predisposition of AF underlying common variants is associated with ischemic stroke and thromboembolism independent of clinical risk factors. But its role in different AF populations, like early onset AF, remains further investigation.Figure 1

Abstract WMP105: Association of Comorbidities, Stroke Etiology, and Polygenic Risk Score in Japanese Ischemic Stroke Patients

Genetic risk impacts stroke mortality and pathogenesis in patients with ischemic stroke: cohort study of BioBank Japan.

Similarities and Differences Between Coronary Heart Disease and Stroke in the Associations with Cardiovascular Risk Factors: the Japan Collaborative Cohort Study.

Recurrent stroke prediction by applying a stroke polygenic risk score in the Japanese population

Association between CPR-related genetic variants and risk of ischemic stroke: a nested case-control study.

Associations of polygenic risk scores with risks of stroke and its subtypes in Chinese

Polygenic risk score for blood pressure and lifestyle factors with overall and CVD mortality: a prospective cohort study in a Japanese population

Development and Validation of a Polygenic Risk Score for Stroke in the Chinese Population

Combined polygenic scores for ischemic stroke risk factors aid risk assessment of ischemic stroke

Clinical and Genetic Atrial Fibrillation Risk and Discrimination of Cardioembolic From Noncardioembolic Stroke

Integrating transcriptomic and polygenic risk scores to enhance predictive accuracy for ischemic stroke subtypes

Abstract P656: Cardioembolic Risk Factors and Ischemic Stroke a Mendelian Randomization Analysis

Interplay between Polygenic Variants Related Immune Response and Lifestyle Factors Mitigate the Chances of Stroke in a Genome-Wide Association Study

The effect of metabolic syndrome defined by various criteria on the development of ischemic stroke subtypes in a general Japanese population

Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients with Cardiometabolic Disease

Periodontitis and Stroke: A Mendelian Randomization Study

Abstract WP394: the Proteasome Subunit Α Type 6 Rs1048990 Contributes to the Risk of Ischemic Stroke and Its Subtypes: New Data and Meta-analysis

Contribution of Common Genetic Variants to Risk of Early-Onset Ischemic Stroke

Associations of combined polygenic risk score and glycemic status with atrial fibrillation, coronary artery disease and ischemic stroke

Association between genetic predisposition of AF and the risk of ischemic stroke and thromboembolism

Exploring Genetic Associations of 3 Types of Risk Factors With Ischemic Stroke: An Integrated Bioinformatics Study